Area of research
Oncology · Molecular Biology
Research interest
Research interests include Neutropenia and Cancer Infections, PARP inhibition in cancer therapy, Cancer-related gene regulation, and Protein Degradation and Inhibitors.
Phase 1 study of veliparib (ABT-888), a poly (ADP-ribose) polymerase inhibitor, with carboplatin and paclitaxel in advanced solid malignancies
Randomized Multicenter Phase II Study of Modified Docetaxel, Cisplatin, and Fluorouracil (DCF) Versus DCF Plus Growth Factor Support in Patients With Metastatic Gastric Adenocarcinoma: A Study of the US Gastric Cancer Consortium